Skip to content

Engage With Us


Who We Are

TransCelerate BioPharma Inc. was launched in 2012 as a non-profit organization to improve the health of people around the world by accelerating and enhancing the research and development of innovative new therapies. Our mission is to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design, and facilitate the implementation of solutions designed to drive the efficient, effective, and high-quality delivery of new medicines. 

TransCelerate’s core values, both as an organization and for our employees, encompass the following facets:

  • Excellence: Will be accountable for our actions and produce superior and timely results. Will not compromise quality.
  • Integrity: Trusted. Transparent. Honest. Ethical. Will always act in good faith.
  • Innovation: Empowered. Will be open-minded, future-focused, and agile in decision-making.
  • Collaboration: Will listen, be flexible, be supportive, and be courageous.
  • Respect: Respectful of diversity, act with humility, empathy, and compassion for all.

Interested in joining our team? Email your resume and cover letter to

Have an Idea? Let Us Know!
Give Feedback to an Initiative

Some of our initiatives are currently seeking feedback. If you have interest in providing input please select the initiative name from the dropdown below to complete their information request form. Please provide your email if you require a response to your inquiry. TransCelerate cannot respond through the feedback forms.

Current public calls for comment:

Clinical Content & Reuse Clinical Template Suite eTemplates

Digital Data Flow Discussion Forum (Clinical Technology Solution Providers)


BioCelerate NCP Template Download Request

The TransCelerate Clinical Content & Reuse (CC&R) team launched the technology enabled edition of the Common Protocol Template (eCPT) in 2016 with subsequent release of the full Clinical Template Suite (CTS) – including the Statistical Analysis Plan (eSAP) & Clinical Study Report (eCSR) – following in 2018.  Since that time, the CC&R team has gained insight on the implementation of the eTemplates by TransCelerate member companies via periodic voluntary, blinded impact surveys, but has only received insights into broader implementation via unsolicited feedback through the TransCelerate website or inferences from CC&R asset download statistics.

In 2023, the CC&R team hopes to establish a future-looking sustainability plan for the CTS within the Clinical Research ecosystem.  In order to do that, the CC&R team would like to gain more meaningful and robust insight to the extent of implementation across the clinical research landscape.

To that end, we are requesting your input on a brief voluntary survey regarding use of the technology enabled CTS  eTemplates (eCPT, eSAP, eCSR). Access the survey here.

CC&R Feedback

Share Your Implementation Experience

Join Our Awareness & Implementation Community

TransCelerate’s mission can only be realized when the benefits that stem from TransCelerate solution adoption are being felt by stakeholders across the R&D ecosystem. 

By signing up for this community, you’ll be the first to learn when: new solutions are available for download, educational webinars are being hosted by solution experts, impactful solutions testimonials are reported, and new tools are available to assist you on your awareness and implementation journey.

Global Headquarters

TransCelerate BioPharma executive offices are located at:

TransCelerate BioPharma Inc.

300 Four Falls Corporate Center

300 Conshohocken State Road
STE 420
West Conshohocken, PA 19428